Kotak Healthcare Fund
- NAV as on 25 Sep 2026
- ₹17.23-0.35%1 day
- Return since launch
- 21.5%
- 52-week range
- ₹12.59 — ₹17.43
- AUM
- ₹768 Cr
Kotak Healthcare Fund is a Sectoral-Pharma equity fund from Kotak Mahindra Mutual Fund with ₹768 Cr under management, launched in 2023. The expense ratio is 2.60% and the SEBI riskometer reading is Very High.
Performance
Kotak Healthcare Fund NAV and returns
Growth of the fund against its category average over the period you pick.
Over 1Y this fund returned +30.9% against +19.5% for its category.
Performance
Returns
How the fund has done against its category and its benchmark.
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1Y | 42.2% | +21.3 pts | 20.9% | 26.4% |
| 2Y | 23.7% | +6.9 pts | 16.8% | 15.2% |
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1M | 1.4% | +1.3 pts | 0.2% | -0.3% |
| 3M | 8.4% | +2.2 pts | 6.2% | 6.0% |
| 6M | 29.0% | +6.8 pts | 22.1% | 20.9% |
| 1Y | 31.0% | +10.1 pts | 20.9% | 19.5% |
| 2Y | 11.1% | +2.9 pts | 8.2% | 6.5% |
Since launch (20 Nov 2023): 21.5%
Calendar-year returns
Category averageShow as a table
| Period | Fund | vs category | Category |
|---|---|---|---|
| 2025 | -7.3% | −5.3 pts | -2.0% |
| 2024 | 39.1% | −1.8 pts | 40.9% |
Returns over one year are annualised. Shorter periods are absolute.
Costs & terms
Costs and terms
What the fund charges each year, and the rules around putting money in and taking it out.
Costs
2.55%
Expense ratio as on 22 Sep 2026
Charged yearly and already deducted from the NAV.
- Base expense
- 1.99%
- Brokerage
- 0.04%
- Transaction charges
- 0.00%
- Statutory levies
- 0.52%
- Exit load
- 0.5% for redemption within 30 Days
- Lock-in
- None
Terms
- Min SIP
- ₹3,000
- Min lumpsum
- ₹5,000
- Plan
- GROWTH
- Fund type
- OPEN-ENDED
- Benchmark
- NIFTY Healthcare TRI.
- Short-term capital gains
- Returns taxed at 20% if you redeem before 1 year
- Long-term capital gains
- After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%
Risk
Risk
What the riskometer means for this fund, and how its ratios sit against the category.
Your principal is treated as being at very high risk — typically small cap, sectoral and thematic equity schemes.
Portfolio
Kotak Healthcare Fund portfolio
Portfolio as of 31 Aug 2026
Asset allocation
- Equity99.7%
- Other0.3%
Market cap split
- Large35.0%
- Mid21.0%
- Small44.0%
- P/E
- 50.85
- P/B
- 6.58
Top holdings
| Holding | Sector | Weight | Value | 3M chg | 6M chg | 1Y chg |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 13.96% | ₹107 Cr | +13.01% | +12.53% | +12.98% |
| Divi's Laboratories Ltd. | Healthcare | 9.25% | ₹71.00 Cr | +5.95% | +5.94% | +5.25% |
| Torrent Pharmaceuticals Ltd. | Healthcare | 4.75% | ₹36.48 Cr | — | — | — |
| company:20769 | Healthcare | 4.53% | ₹34.76 Cr | — | — | — |
| Max Healthcare Institute Ltd. | Healthcare | 4.34% | ₹33.35 Cr | +5.43% | +7.31% | +7.54% |
| Acutaas Chemicals Ltd. | Healthcare | 3.91% | ₹30.03 Cr | +4.92% | +4.00% | +2.71% |
| Cipla Ltd. | Healthcare | 3.67% | ₹28.18 Cr | +5.00% | +4.17% | +5.79% |
| Park Medi World Ltd. | Healthcare | 3.36% | ₹25.79 Cr | +4.20% | +3.23% | — |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 3.25% | ₹24.92 Cr | +2.92% | +3.22% | +4.32% |
| Yatharth Hospital & Trauma Care Services Ltd. | Healthcare | 3.25% | ₹24.95 Cr | +1.28% | +1.32% | +1.34% |
| Gland Pharma Ltd. | Healthcare | 3.04% | ₹23.38 Cr | +2.01% | +2.58% | +2.81% |
| Sai Life Sciences Ltd. | Healthcare | 3.04% | ₹23.36 Cr | +2.90% | +2.98% | +2.12% |
| Fortis Healthcare Ltd. | Healthcare | 2.95% | ₹22.67 Cr | +4.31% | +5.05% | +3.90% |
| Mankind Pharma Ltd. | Healthcare | 2.84% | ₹21.77 Cr | +3.18% | +1.85% | +2.65% |
| Marksans Pharma Ltd. | Healthcare | 2.51% | ₹19.30 Cr | +2.20% | +1.79% | +1.59% |
| Laurus Labs Ltd. | Healthcare | 2.49% | ₹19.15 Cr | +1.95% | — | — |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 2.46% | ₹18.89 Cr | +3.12% | +3.07% | +2.33% |
| Rubicon Research Ltd. | Healthcare | 2.37% | ₹18.20 Cr | +1.80% | +1.66% | — |
| Anthem Biosciences Ltd. | Healthcare | 2.33% | ₹17.86 Cr | +2.44% | +2.46% | +2.75% |
| Ajanta Pharma Ltd. | Healthcare | 2.11% | ₹16.21 Cr | +2.20% | +2.78% | +2.09% |
| company:6832 | Healthcare | 2.01% | ₹15.42 Cr | — | — | — |
| Orchid Pharma Ltd. | Healthcare | 1.64% | ₹12.62 Cr | +1.70% | +1.28% | +1.57% |
| CORONA Remedies Ltd. | Healthcare | 1.60% | ₹12.30 Cr | +1.65% | +1.91% | — |
| Aurobindo Pharma Ltd. | Healthcare | 1.57% | ₹12.02 Cr | +2.29% | +2.54% | +2.22% |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.57% | ₹12.06 Cr | +1.51% | +1.50% | — |
| Jubilant Ingrevia Ltd. | Chemicals | 1.49% | ₹11.47 Cr | — | — | — |
| Rainbow Children's Medicare Ltd. | Healthcare | 1.29% | ₹9.90 Cr | +1.48% | +1.10% | +1.50% |
| company:2820 | Healthcare | 1.16% | ₹8.90 Cr | — | — | — |
| Jubilant Pharmova Ltd. | Healthcare | 1.15% | ₹8.84 Cr | +2.40% | +2.50% | +3.07% |
| Lupin Ltd. | Healthcare | 1.14% | ₹8.75 Cr | +2.63% | +4.51% | +3.86% |
| Metropolis Healthcare Ltd. | Healthcare | 1.14% | ₹8.74 Cr | +1.09% | — | — |
| Zydus Lifesciences Ltd. | Healthcare | 1.13% | ₹8.71 Cr | +1.35% | +1.52% | +1.68% |
| Dr. Lal Pathlabs Ltd. | Healthcare | 1.11% | ₹8.51 Cr | +1.26% | — | — |
| Innova Captab Ltd. | Healthcare | 1.08% | ₹8.30 Cr | +1.17% | +1.06% | +1.93% |
| Others | Others | 0.34% | ₹2.47 Cr | -0.32% | -0.30% | -0.50% |
| Laxmi Dental Ltd. | Healthcare | 0.17% | ₹1.27 Cr | +1.18% | +1.19% | +1.53% |
Sectors
Instruments
Recent changes
| Holding | From | To | Weight |
|---|---|---|---|
| company:20769 | 0.00% | 4.53% | +4.53% |
| company:6832 | 0.00% | 2.01% | +2.01% |
| Torrent Pharmaceuticals Ltd. | 6.16% | 4.75% | -1.41% |
| Others | -0.27% | -1.43% | -1.16% |
| company:2820 | 0.00% | 1.16% | +1.16% |
| Divi's Laboratories Ltd. | 8.26% | 9.25% | +0.99% |
| Sun Pharmaceutical Industries Ltd. | 14.88% | 13.96% | -0.92% |
| Max Healthcare Institute Ltd. | 5.15% | 4.34% | -0.81% |
| Cipla Ltd. | 4.32% | 3.67% | -0.65% |
| Apollo Hospitals Enterprise Ltd. | 2.63% | 3.25% | +0.62% |
| Fortis Healthcare Ltd. | 3.46% | 2.95% | -0.51% |
| Park Medi World Ltd. | 3.86% | 3.36% | -0.50% |
| Krishna Institute of Medical Sciences Ltd | 2.95% | 2.46% | -0.49% |
| Laxmi Dental Ltd. | 0.64% | 0.17% | -0.47% |
| Mankind Pharma Ltd. | 3.26% | 2.84% | -0.42% |
| Acutaas Chemicals Ltd. | 4.32% | 3.91% | -0.41% |
| Jubilant Ingrevia Ltd. | 1.83% | 1.49% | -0.34% |
| Emcure Pharmaceuticals Ltd. | 1.87% | 1.57% | -0.30% |
| Gland Pharma Ltd. | 2.75% | 3.04% | +0.29% |
| Lupin Ltd. | 1.42% | 1.14% | -0.28% |
| Rainbow Children's Medicare Ltd. | 1.56% | 1.29% | -0.27% |
| Yatharth Hospital & Trauma Care Services Ltd. | 2.99% | 3.25% | +0.26% |
| CORONA Remedies Ltd. | 1.85% | 1.60% | -0.25% |
| Orchid Pharma Ltd. | 1.88% | 1.64% | -0.24% |
| Marksans Pharma Ltd. | 2.27% | 2.51% | +0.24% |
| Jubilant Pharmova Ltd. | 1.37% | 1.15% | -0.22% |
| Rubicon Research Ltd. | 2.18% | 2.37% | +0.19% |
| Ajanta Pharma Ltd. | 2.29% | 2.11% | -0.18% |
| Laurus Labs Ltd. | 2.66% | 2.49% | -0.17% |
| Metropolis Healthcare Ltd. | 1.28% | 1.14% | -0.14% |
| Dr. Lal Pathlabs Ltd. | 1.23% | 1.11% | -0.12% |
| Zydus Lifesciences Ltd. | 1.24% | 1.13% | -0.11% |
| Aurobindo Pharma Ltd. | 1.62% | 1.57% | -0.05% |
| Anthem Biosciences Ltd. | 2.37% | 2.33% | -0.04% |
| Sai Life Sciences Ltd. | 3.08% | 3.04% | -0.04% |
| Innova Captab Ltd. | 1.10% | 1.08% | -0.02% |
Compare
Similar funds
The rest of the category, so this fund’s numbers have something to sit against.
| Fund | AUM | Expense | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Category average | ₹3,579 Cr | 2.19% | 27.3% | 17.7% | 20.1% |
 ICICI Prudential Healthcare Fund | ₹6,996 Cr | 2.07% | 14.5% | 14.2% | 19.4% |
 SBI Healthcare Opportunities Fund | ₹5,796 Cr | 1.99% | 33.1% | 19.9% | 22.2% |
 Mirae Asset Healthcare Fund | ₹3,555 Cr | 2.03% | 29.9% | 18.4% | 19.7% |
 UTI Healthcare Fund | ₹1,444 Cr | 2.21% | 30.4% | 19.1% | 21.1% |
 LIC MF Healthcare Fund | ₹103 Cr | 2.67% | 28.7% | 16.9% | 17.9% |
About
About this fund
The scheme’s own words, its benchmark and the people running it.
Investment objective
The scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.
Fund managers
- Abhishek BisenMr. Bisen is a BA and MBA in Finance.Prior to joining Kotak AMC, he was working with Securities Trading Corporation Of India Ltd where he was looking at Sales & Trading of Fixed Income Products apart from doing Portfolio Advisory. His earlier assignments also include 2 years of merchant banking experience with a leading merchant banking firm.
- Dhananjay TikarihaMr. Tikariha has done B.Tech, M. Tech from IIT Madras and PGDM (Finance & Marketing) from IIM LucknowPrior to joining Kotak Mahindra Mutual Fund, he has worked with IDFC First Bank
Tools
Return calculator
What ₹10,000 a month in this fund would have grown to over each period, based on its past returns.
| Over the past | Total investment | Would’ve become | Growth | Returns |
|---|---|---|---|---|
| 6 months28.96% absolute | ₹60,000 | ₹77,376 | 28.96% | |
| 1 year30.96% annualised | ₹1,20,000 | ₹1,42,156 | 18.46% |
Returns for 1 year and longer are annualised (CAGR); 6-month figures are absolute. Past returns are not a forecast.
How this is calculated
Each monthly instalment grows at the fund’s annualised return ÷ 12 per month until the end of the period, the same formula as our SIP calculator.
The amount compounds once a year at the fund’s CAGR for that period, the same formula as our lumpsum calculator.
Questions
Frequently asked questions
The things people ask about this scheme.